FDA Approves Expanded Indication for Anktiva in BCG-Unresponsive NMIBC
Oct 15, 2026
View online
FDA Approves Expanded Indication for Anktiva in BCG-Unresponsive NMIBC
Giuseppe Curigliano Announces Milan as Host City for ESMO Congress 2028
PharmaMar Joins OncoDaily Grand Rounds at ESMO 2026: Sarcoma Edition as Foundational Partner
Michael Bailey Named Next CEO of Verastem Oncology
Jazz EMERGE 402: Real-World Lurbinectedin Shows Clinically Meaningful Activity in Previously Treated SCLC
Herbert Loong: APODDC Working Group’s Recommendations on Leveraging Real-world Evidence in Oncology
Does 7+3 Still Hold Its Ground in AML? How Venetoclax Is Challenging Intensive Induction
Episode 1 of gastrochat: H. pylori, TikTok, and a Whole Lot of Drama
Spanish Association Against Cancer — Postdoctoral AECC 2027
AACR–Lustgarten Foundation Ruth Bader Ginsburg Career Development Award 2027
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
